Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News
SAN DIEGO, CA, July 26, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. ( OTC: MJNA ) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its CEO Blake Schroeder has published an article in Nasdaq News to provide the industry with insight on the future of federal cannabis legalization in the U.S. In his article titled, “How Using the CBD Marketplace Can Set a Strong Stage for U.S. Cannabis” , Blake explains how the non-psychoactive hemp CBD market presents a unique opportunity to build a customer base and lay the groundwork for psychoactive tetrahydrocannabinol (THC) product sales once federally legal. He explains how the THC market, which is currently only legal on a state-by-state basis, can learn from the regulatory, testing, banking, legal, and other business related challeng...